Display options
Cite
Marshall JK, Irvine EJ. Lymphocytic and Collagenous Colitis: Medical Management. Curr Treat Options Gastroenterol. 1999;2(2):127-133doi: 10.1007/s11938-999-0040-3.
Marshall, J. K., & Irvine, E. J. (1999). Lymphocytic and Collagenous Colitis: Medical Management. Current treatment options in gastroenterology, 2(2), 127-133. https://doi.org/10.1007/s11938-999-0040-3
Marshall, and Irvine. "Lymphocytic and Collagenous Colitis: Medical Management." Current treatment options in gastroenterology vol. 2,2 (1999): 127-133. doi: https://doi.org/10.1007/s11938-999-0040-3
Marshall JK, Irvine EJ. Lymphocytic and Collagenous Colitis: Medical Management. Curr Treat Options Gastroenterol. 1999 Apr;2(2):127-133. doi: 10.1007/s11938-999-0040-3. PMID: 11096583.
Copy Download .nbib Format: NLM
Share it on

Curr Treat Options Gastroenterol. 1999 Apr;2(2):127-133. doi: 10.1007/s11938-999-0040-3.

Lymphocytic and Collagenous Colitis: Medical Management.

Current treatment options in gastroenterology

Marshall, Irvine

Affiliations

  1. Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

PMID: 11096583 DOI: 10.1007/s11938-999-0040-3

Abstract

When possible, patients taking nonsteroidal anti-inflammatory medications should discontinue them when the diagnosis of microscopic colitis is made. Although there is no direct evidence of its efficacy, a trial of elimination of caffeine or lactose or both should be undertaken. Nonspecific antidiarrheal agents (eg, loperamide, diphenoxylate) may be administered, but appear to be largely ineffective in this population. An aminosalicylate should be initiated at full therapeutic dose (2 to 4 g daily) as the first-line therapy. Because sulfasalazine appears to be associated with a high incidence of adverse effects in patients with microscopic colitis, other derivatives of 5-aminosalicylate (5-ASA) are preferred. Bile salt-binding agents such as cholestyramine or colestipol appear to be effective alternatives for patients who are either unresponsive to or intolerant of aminosalicylates. Systemic corticosteroids are an effective treatment for microscopic colitis, but may offer only transient improvement in symptoms. Given their potential adverse effects, corticosteroids should be reserved for patients with refractory disease in whom aminosalicylates and bile salt-binding agents have failed. Other agents that may be effective include antibiotics, bismuth subsalicylate, budesonide, pentoxifylline, octreotide, and methotrexate. Although these agents can be considered in unusual cases, the cumulative clinical experience with them in this setting is relatively limited. Surgical intervention, with either fecal stream diversion or subtotal colectomy, shows promise as an intervention of last resort. In refractory cases of microscopic colitis, strong consideration should be given to excluding a concomitant diagnosis of celiac disease, bacterial overgrowth, or chronic infection.

References

  1. Gastroenterol Clin North Am. 1995 Sep;24(3):717-29 - PubMed
  2. Schweiz Med Wochenschr. 1993 Jul 31;123(30):1487-90 - PubMed
  3. Am J Gastroenterol. 1995 Sep;90(9):1394-400 - PubMed
  4. J Clin Gastroenterol. 1996 Dec;23(4):300-1 - PubMed
  5. Dis Colon Rectum. 1996 May;39(5):573-8 - PubMed
  6. Gut. 1992 Jan;33(1):65-70 - PubMed
  7. Pathol Eur. 1976;11(1):87-9 - PubMed
  8. Gut. 1996 Dec;39(6):846-51 - PubMed
  9. Gut. 1996 May;38(5):788-91 - PubMed
  10. Am J Gastroenterol. 1999 Jul;94(7):1871-5 - PubMed
  11. Gut. 1995 Jun;36(6):880-6 - PubMed
  12. Am J Surg Pathol. 1996 Sep;20(9):1102-9 - PubMed
  13. Mayo Clin Proc. 1995 May;70(5):430-3 - PubMed
  14. Dis Colon Rectum. 1984 Oct;27(10):672-6 - PubMed
  15. Gut. 1992 May;33(5):683-6 - PubMed
  16. Ann Pathol. 1996 Dec;16(6):430-4 - PubMed
  17. Gastroenterology. 1998 Jan;114(1):29-36 - PubMed
  18. J Intern Med. 1991 May;229(5):443-6 - PubMed
  19. Histopathology. 1996 Aug;29(2):101-10 - PubMed
  20. Gastroenterology. 1997 Jun;112(6):1830-8 - PubMed
  21. Gastroenterology. 1985 Mar;88(3):792-7 - PubMed
  22. Am J Gastroenterol. 1997 Jan;92(1):57-60 - PubMed
  23. Gastroenterology. 1995 Aug;109(2):449-55 - PubMed
  24. Gastroenterol Clin Biol. 1993;17(12):976-7 - PubMed
  25. Pathol Res Pract. 1990 Apr;186(2):303-6; discussion 306-8 - PubMed
  26. Am J Gastroenterol. 1998 Feb;93(2):270 - PubMed
  27. Am J Gastroenterol. 1997 Jul;92(7):1213-5 - PubMed
  28. Ital J Gastroenterol. 1996 Apr;28(3):147-51 - PubMed
  29. Aust N Z J Med. 1996 Feb;26(1):114 - PubMed
  30. Gastroenterology. 1986 Dec;91(6):1583-4 - PubMed
  31. Mayo Clin Proc. 1987 Aug;62(8):665-71 - PubMed
  32. Can J Gastroenterol. 1996 Nov-Dec;10(7):436-9 - PubMed

Publication Types